Affymax, Inc. (Nasdaq:AFFY) today announced the CompanyÂ™s participation at the following investor conferences in August.
|Arlene Morris, president and chief executive officer, will present at BMO Capital Markets Focus on Healthcare 2008 Investor Conference|
|Millennium Broadway Hotel, New York City|
|Tuesday, August 5|
|3:30 p.m. ET|
|Chris Dammann, vice president of Business Development, will present at Bank of America 2008 Specialty Pharmaceuticals Conference|
|Southampton Inn, Long Island, NY|
|Thursday, August 7, 2008|
|10:15 a.m. ET|
A live webcast of the presentation will be available on the investors section of the companyÂ™s website at www.affymax.com. A replay will also be available for 30 days following the presentation.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. AffymaxÂ™s lead product candidate, HematideÂ„, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure and in a Phase 1 clinical trial for the treatment of anemia in cancer patients. For additional information, please visit www.affymax.com.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications